What INVIMA actually does
INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) functions similarly to the US FDA — regulating the approval and monitoring of medical devices, pharmaceuticals, and implantable materials used in Colombian healthcare, including the same implant brands (Straumann, Nobel Biocare, major breast implant manufacturers) used in US practices.
How this differs from hospital accreditation
INVIMA oversight applies to products and materials; JCI and acreditación apply to facilities and clinical processes; SCCP and specialty boards apply to individual physician credentials. These are three separate, complementary layers — not redundant, and not substitutes for one another.
Why this matters practically
When a Colombian clinic states they use a specific implant brand via colombiacosmeticsurgery.com or colombiadentist.co, INVIMA's regulatory oversight is part of why that claim is verifiable and meaningful, not just a marketing statement.
The Takeaway
Colombia's regulatory structure has multiple, distinct layers of oversight — understanding which layer covers what helps you ask more precise verification questions.